David Larsen
Stock Analyst at BTIG
(2.07)
# 2,839
Out of 4,734 analysts
74
Total ratings
35.09%
Success rate
-2.46%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $27.85 | +25.67% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $102.42 | +26.93% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $25.07 | +23.65% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $197.36 | +31.74% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $29.92 | +67.11% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $18.55 | +7.82% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $35.17 | +99.03% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $3.94 | +77.66% | 1 | Sep 17, 2024 | |
| PGNY Progyny | Downgrades: Neutral | n/a | $21.00 | - | 3 | Aug 7, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $216.59 | +10.81% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $4.17 | +67.87% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $4.90 | +185.71% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.21 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $42.57 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $53.72 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $10.00 | +350.00% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $5.49 | +282.51% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $3.09 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.89 | - | 2 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.24 | +57.37% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.09 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $7.50 | +1,166.67% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $9.55 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $126.27 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $592.57 | -73.00% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $12.52 | +459.11% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.22 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $52.62 | +61.54% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $14.58 | +57.75% | 1 | Nov 2, 2017 |
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $27.85
Upside: +25.67%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $102.42
Upside: +26.93%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $25.07
Upside: +23.65%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $197.36
Upside: +31.74%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $29.92
Upside: +67.11%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $18.55
Upside: +7.82%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $35.17
Upside: +99.03%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.94
Upside: +77.66%
Progyny
Aug 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $21.00
Upside: -
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $216.59
Upside: +10.81%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $4.17
Upside: +67.87%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $4.90
Upside: +185.71%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.21
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $42.57
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $53.72
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $10.00
Upside: +350.00%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $5.49
Upside: +282.51%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $3.09
Upside: -
Apr 29, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.89
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.24
Upside: +57.37%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $9.09
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $7.50
Upside: +1,166.67%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $9.55
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $126.27
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $592.57
Upside: -73.00%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $12.52
Upside: +459.11%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.22
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $52.62
Upside: +61.54%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $14.58
Upside: +57.75%